DK1032386T3 - Anvendelse af oxazolidinonderivater til behandling af arthritis - Google Patents

Anvendelse af oxazolidinonderivater til behandling af arthritis

Info

Publication number
DK1032386T3
DK1032386T3 DK98960157T DK98960157T DK1032386T3 DK 1032386 T3 DK1032386 T3 DK 1032386T3 DK 98960157 T DK98960157 T DK 98960157T DK 98960157 T DK98960157 T DK 98960157T DK 1032386 T3 DK1032386 T3 DK 1032386T3
Authority
DK
Denmark
Prior art keywords
arthritis
treatment
oxazolidinone derivatives
psoriasis
oxazolidinone
Prior art date
Application number
DK98960157T
Other languages
English (en)
Inventor
Donald H Batts
Roger G Ulrich
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK1032386T3 publication Critical patent/DK1032386T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK98960157T 1997-11-18 1998-11-10 Anvendelse af oxazolidinonderivater til behandling af arthritis DK1032386T3 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US6568997P 1997-11-18 1997-11-18
US7129798P 1998-01-16 1998-01-16
US7366298P 1998-02-04 1998-02-04
US7524798P 1998-02-19 1998-02-19
US7767298P 1998-03-12 1998-03-12
PCT/US1998/023233 WO1999025344A1 (en) 1997-11-18 1998-11-10 Use of oxazolidinone derivatives for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy

Publications (1)

Publication Number Publication Date
DK1032386T3 true DK1032386T3 (da) 2003-05-26

Family

ID=27535698

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98960157T DK1032386T3 (da) 1997-11-18 1998-11-10 Anvendelse af oxazolidinonderivater til behandling af arthritis

Country Status (15)

Country Link
EP (1) EP1032386B1 (da)
JP (1) JP2001522886A (da)
KR (2) KR100589545B1 (da)
CN (2) CN1546030A (da)
AT (1) ATE233092T1 (da)
AU (1) AU743941B2 (da)
BR (1) BR9815615A (da)
CA (1) CA2303961A1 (da)
DE (1) DE69811717T2 (da)
DK (1) DK1032386T3 (da)
ES (1) ES2193592T3 (da)
NZ (1) NZ504612A (da)
PT (1) PT1032386E (da)
SI (1) SI1032386T1 (da)
WO (1) WO1999025344A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200003595T2 (tr) 1998-06-05 2001-07-23 Astrazeneca Ab Kimyasal bileşikler
ATE337002T1 (de) * 1999-09-13 2006-09-15 Insite Vision Inc Topische behandlung zur vorbeugung von augeninfektionen
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
US6451345B1 (en) 2000-01-20 2002-09-17 Eurand Pharmaceuticals Ltd. Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
IL139975A0 (en) * 2000-11-29 2002-02-10 Univ Ramot Anti proliferative drugs
WO2005060951A2 (en) * 2003-12-19 2005-07-07 Bionaut Pharmaceuticals, Inc. Anti-neoplastic agents, combination therapies and related methods
CN107456442A (zh) * 2016-06-03 2017-12-12 四川赛卓药业股份有限公司 一种噁唑烷酮化合物的亚微乳注射剂及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE146783T1 (de) * 1991-11-01 1997-01-15 Upjohn Co Substituierte aryl- und heteroaryl- phenyloxazolidinone
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
EP0730591B1 (en) * 1993-11-22 1999-07-14 PHARMACIA & UPJOHN COMPANY Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones

Also Published As

Publication number Publication date
AU743941B2 (en) 2002-02-07
CN1546030A (zh) 2004-11-17
WO1999025344A1 (en) 1999-05-27
KR100589545B1 (ko) 2006-06-19
DE69811717T2 (de) 2003-10-16
CN1299281A (zh) 2001-06-13
EP1032386B1 (en) 2003-02-26
KR20050100009A (ko) 2005-10-17
DE69811717D1 (de) 2003-04-03
KR100574307B1 (ko) 2006-04-27
ATE233092T1 (de) 2003-03-15
KR20010032178A (ko) 2001-04-16
AU1582399A (en) 1999-06-07
SI1032386T1 (en) 2003-06-30
NZ504612A (en) 2002-08-28
BR9815615A (pt) 2000-10-24
JP2001522886A (ja) 2001-11-20
PT1032386E (pt) 2003-07-31
CA2303961A1 (en) 1999-05-27
CN1142777C (zh) 2004-03-24
HK1036591A1 (en) 2002-01-11
EP1032386A1 (en) 2000-09-06
ES2193592T3 (es) 2003-11-01

Similar Documents

Publication Publication Date Title
DE50214206D1 (de) Kombinationstherapie substituierter oxazolidinone
ES2116801T3 (es) Empleo de derivados de adamantano para el tratamiento de tinnitus.
NZ515567A (en) Method for treating chronic pain using MEK inhibitors
NZ307509A (en) Use of 1L agonists in the treatment of incontinence
BG106825A (en) Substituted oxazolidinones and their use in the field of blood coagulation
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
ES2165441T3 (es) Inhibidores de calpaina y/o catepsina b oxazolidin sustituidos.
ES2166111T3 (es) Uso de tiagabina para el tratamiento de trastornos del sueño.
ES2113081T3 (es) 1,4-benzotiazepinas utiles como agentes neurologicos.
BR0107667A (pt) Composto de linezolida em forma de cristal que e farmaceuticamente útil como agente antibacteriano e método de preparação do mesmo
DE60016460D1 (de) Verwendungen und zusammenstellungen von nitratestern als sedativa
IL142047A0 (en) Mglur5 antagonists for the treatment of pain and anxiety
ID21472A (id) Senyawa terbaru yang berguna sebagai agen pelindung saraf
DK1032386T3 (da) Anvendelse af oxazolidinonderivater til behandling af arthritis
FI950403A0 (fi) Neurosuojaavia yhdisteitä
DE60128100D1 (de) Analgetisches arzneimittel
EA199800864A1 (ru) Способ лечения при боли, вызванной мигренью
NO169229C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-(3-alkyl-5-tert.butyl-4-hydroksyfenyl)-2-amino-6h-1,3,4-tiadiaziner
PT1147105E (pt) Derivado de piridil-4h-1,2,4-oxadiazina opticamente activo e sua utilizacao no tratamento de doencas vasculares
JO3446B1 (ar) طريقة لمعالجة الأرق الأولي
MY137595A (en) N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide for the treatment of cancer
DE69904465D1 (de) Therapie von depressionen
DK1304107T3 (da) Anvendelse af oxozolidinonderivater til behandling af psoriasis
EA199800085A1 (ru) Способ лечения боли висцерального происхождения, способ лечения воспалительного колита
SE9800139D0 (sv) New use